1. Home
  2. RGNX vs NBR Comparison

RGNX vs NBR Comparison

Compare RGNX & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • NBR
  • Stock Information
  • Founded
  • RGNX 2008
  • NBR 1952
  • Country
  • RGNX United States
  • NBR Bermuda
  • Employees
  • RGNX N/A
  • NBR N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • NBR Oil & Gas Production
  • Sector
  • RGNX Health Care
  • NBR Energy
  • Exchange
  • RGNX Nasdaq
  • NBR Nasdaq
  • Market Cap
  • RGNX 424.8M
  • NBR 417.7M
  • IPO Year
  • RGNX 2015
  • NBR N/A
  • Fundamental
  • Price
  • RGNX $8.70
  • NBR $32.85
  • Analyst Decision
  • RGNX Strong Buy
  • NBR Hold
  • Analyst Count
  • RGNX 8
  • NBR 8
  • Target Price
  • RGNX $31.75
  • NBR $44.50
  • AVG Volume (30 Days)
  • RGNX 788.1K
  • NBR 525.7K
  • Earning Date
  • RGNX 07-31-2025
  • NBR 07-29-2025
  • Dividend Yield
  • RGNX N/A
  • NBR N/A
  • EPS Growth
  • RGNX N/A
  • NBR N/A
  • EPS
  • RGNX N/A
  • NBR N/A
  • Revenue
  • RGNX $156,718,000.00
  • NBR $2,932,608,000.00
  • Revenue This Year
  • RGNX $327.08
  • NBR $13.65
  • Revenue Next Year
  • RGNX N/A
  • NBR $5.53
  • P/E Ratio
  • RGNX N/A
  • NBR N/A
  • Revenue Growth
  • RGNX 80.70
  • NBR N/A
  • 52 Week Low
  • RGNX $5.04
  • NBR $23.27
  • 52 Week High
  • RGNX $15.36
  • NBR $105.96
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 48.91
  • NBR 55.06
  • Support Level
  • RGNX $8.39
  • NBR $33.28
  • Resistance Level
  • RGNX $9.27
  • NBR $35.66
  • Average True Range (ATR)
  • RGNX 0.53
  • NBR 1.92
  • MACD
  • RGNX 0.03
  • NBR 0.33
  • Stochastic Oscillator
  • RGNX 59.86
  • NBR 66.86

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About NBR Nabors Industries Ltd.

Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.

Share on Social Networks: